Bausch Health Companies (BHC) Current Deferred Tax Assets (2010 - 2015)

Bausch Health Companies' (BHC) quarterly Current Deferred Tax Assets came in at $727.2 million in Q3 2015, up 129.84% year-on-year from $316.4 million in Q3 2014, and up 2.22% quarter-over-quarter from $711.4 million in Q2 2015.

Bausch Health Companies (BHC) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends

Bausch Health Companies has disclosed Current Deferred Tax Assets across 6 years of filings, most recently posting $727.2 million for Q3 2015.

  • Current Deferred Tax Assets for Q3 2015 came in at $727.2 million, up 129.84% year-over-year; the trailing twelve-month figure through Sep 2015 was $727.2 million (up 129.84% YoY), and the FY2014 annual result was $193.3 million, down 47.32% from the prior year.
  • Current Deferred Tax Assets came in at $727.2 million for Q3 2015 at Bausch Health Companies, up from $711.4 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $727.2 million in Q3 2015 to a low of $77.5 million in Q3 2011.
  • The 5-year median for Current Deferred Tax Assets is $196.5 million (2015), against an average of $252.5 million.
  • Across the five-year window, Current Deferred Tax Assets jumped 540.48% in 2011 and slumped 47.32% in 2014, its largest moves.
  • Bausch Health Companies' Current Deferred Tax Assets stood at $148.5 million in 2011, then soared by 31.36% to $195.0 million in 2012, then jumped by 88.15% to $366.9 million in 2013, then slumped by 47.32% to $193.3 million in 2014, then jumped by 276.2% to $727.2 million in 2015.
  • The last three Current Deferred Tax Assets figures came in at $727.2 million (Q3 2015), $711.4 million (Q2 2015), and $196.5 million (Q1 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Bausch Health Companies 1.91 Bn 1.58 Bn 2.48 Bn

Historic Data

Download Data
DateValue
Sep 30, 2015 727.20 Mn
Sep 30, 2015 727.20 Mn
Jun 30, 2015 711.40 Mn
Jun 30, 2015 711.40 Mn
Mar 31, 2015 196.50 Mn
Mar 31, 2015 196.50 Mn
Dec 31, 2014 193.30 Mn
Dec 31, 2014 193.30 Mn
Sep 30, 2014 316.40 Mn
Sep 30, 2014 316.40 Mn
Jun 30, 2014 309.80 Mn
Jun 30, 2014 309.80 Mn
Mar 31, 2014 315.30 Mn
Mar 31, 2014 315.30 Mn
Dec 31, 2013 366.90 Mn
Dec 31, 2013 366.90 Mn
Sep 30, 2013 221.93 Mn
Sep 30, 2013 221.93 Mn
Jun 30, 2013 198.67 Mn
Jun 30, 2013 198.67 Mn